4.7 Review

Cadherins as novel targets for anti-cancer therapy

Journal

EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 625, Issue 1-3, Pages 195-198

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2009.05.033

Keywords

Cadherin; Blood vessel; Angiogenesis; Metastasis

Funding

  1. Canadian Institutes of Health Research
  2. Adherex Technologies Incorporated

Ask authors/readers for more resources

The cell adhesion molecules N-, VE- and OB-cadherin have been implicated as regulators of tumor growth and metastasis. We discuss evidence that N- and VE-cadherin play a key role in promoting blood vessel formation and stability, processes which are essential for tumor growth. Secondly, we describe the potential involvement of N- and CB-cadherin in the metastatic process. Finally, studies concerning the effects of the N-cadherin antagonist designated ADH-1 on tumor growth are presented. Collectively, these observations suggest that antagonists of N, VE- and OB-cadherin would be useful as anti-cancer agents. (C) 2009 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available